Anemia Study in Chronic Kidney Disease (CKD) : Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat -Forearm Blood Flow (ASCEND-FBF)
Clinical trial NCT03446612 · TERMINATED
Trial details
- NCT number
- NCT03446612
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-10
- Primary completion
- 2019-05-29
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.